Chongqing Zhifei Bio Products (300122 SHE) stock market data APIs
¥19.0431
0.38(2%)
as of January 16, 2026
Try our APIs with
free plan!
Chongqing Zhifei Bio Products Financial Data Overview
Price chart is built with
Anychart
Chongqing Zhifei Biological Products Co., Ltd. engages in the research and development, production, marketing, distribution, import, and export of vaccines in China. The company offers Recombinant Novel Coronavirus Vaccine (CHO Cell); Recombinant Mycobacterium Tuberculosis Fusion Protein under the Ekear brand; Haemophilus Influenzae Type b Vaccine under the XiFeiBei brand; ACYW135 Meningococcal Polysaccharide Vaccine under the Menwayc brand; Mycobacterium Vaccae for Injection under the Vaccae brand; Meningococcal Group A and Group C Polysaccharide Conjugate Vaccine under the Mening A Con brand; and other developed products. It also provides cold storage services. Chongqing Zhifei Biological Products Co., Ltd. was founded in 2002 and is based in Chongqing, China.
Prev. Close
19.0431
Open
19.4206
High
19.6212
Low
18.8009
52 wk Range
18.7-27.8
Market Cap
42 370 M
Shares Outstanding
2 394 M
Revenue
10 911 M
EPS
-0.25
Beta
0.768
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Chongqing Zhifei Bio Products (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Chongqing Zhifei Bio Products data using free add-ons & libraries
Get Chongqing Zhifei Bio Products Fundamental Data
Chongqing Zhifei Bio Products Fundamental data includes:
- Net Revenue: 10 911 M
- EBITDA: -943 424 256
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 0.0383
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Chongqing Zhifei Bio Products News
New
Chinese Shares Fall on Continued Concerns Over Economic Outlook
Chinese shares opened lower as investors remain concerned about growth prospects next year for the world’s second largest economy. Continue reading
GSK Partners With Zhifei to Boost Shingles Vaccine Availability in China
GSK said it has an exclusive agreement with Zhifei to co-promote its shingles vaccine Shingrix in China. Continue reading
Demand for Online Doctors Creates $39 Billion Titan in Japan
(Bloomberg) -- Two decades ago, Itaru Tanimura ended a 12-year run at McKinsey & Co. to lead M3 Inc., an online provider of medical information and services backed by entertainment giant Sony Corp. W...
Demand for Online Doctors Creates $39 Billion Titan in Japan
(Bloomberg) -- Two decades ago, Itaru Tanimura ended a 12-year run at McKinsey & Co. to lead M3 Inc., an online provider of medical information and services backed by entertainment giant Sony Corp. W...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
